The tumor suppressor p53 (TP53) is the most frequently mutated gene in numerous tumor types, including prostate cancer (PCa), a tumor type that generally exhibits a low mutational burden [1, 2]. This evidence concerns the gene TP53 and posterior cortical atrophy.